Market Tracker

11/21 6:05pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

15.69
Data as of Nov 21
 -0.66 / -4.04%
Today’s Change
9.71
Today|||52-Week Range
23.95
+55.65%
Year-to-Date

Today’s Trading

Previous close16.35
Today’s open16.49
Day’s range15.63 - 16.49
Volume529,409
Average volume (3 months)468,752
Market cap$511.6M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-3.57%
Earnings growth (next 5 years)+19.40%
Revenue growth (last year)+8.77%
P/E ratio156.9
Price/Sales1.26
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.05-5.47%
EXELExelixis Inc+0.02+1.15%
ARWRArrowhead Research C...+0.16+2.79%
FLXNFlexion Therapeutics...-0.50-2.91%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateFebruary 9, 2015
EPS forecast (this quarter)$0.32
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael Nolan
Corporate headquarters
Albany, New York

Forecasts